Wilhoit Scott L. 4
4 · Strongbridge Biopharma plc · Filed Jun 5, 2019
Insider Transaction Report
Form 4
Wilhoit Scott L.
Chief Commercial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2019-05-28+50,000→ 50,000 totalExercise: $2.84Exp: 2029-05-28→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This option becomes exercisable as to 12,500 shares on May 28, 2020, with the remaining 37,500 shares becoming exercisable in twelve equal quarterly installments thereafter, provided the Reporting Person is employed by the Issuer on each vesting date.